로딩 중…
StockDiggingStockDigging

Takeda Pharmaceutical Company Limited

TAK· NYSE
JPJP
$15.62+1.26%
2026-06-18

Price Chart

Takeda Pharmaceutical Company Limited+4.80%

Financials

※ FY = Fiscal Year

Investment Metrics(as of 2026-06-18)

MetricValue
Size
Market Cap$49.34B
Revenue$30.21B
Net Income$1.28B
Total Assets$97.10B
Net Assets$48.84B
Value
P/E38.44x
P/B1.01x
PEG0.43x
P/S1.63x
EV/EBITDA8.05x
FCF Yield10.20%
Profitability
ROE2.63%
ROA1.32%
Op. Margin10.89%
Revenue Growth5.81%
Earnings Growth88.39%
Financial Health
Debt Ratio98.77%
Total Debt$30.67B
FCF$5.03B
Cash$3.74B
Current Ratio1.27x
Net Debt/EBITDA2.84x
Dividend
Div. Yield4.19%
Div. Growth9.33%
Performance
1Y Return4.80%
1M Return-5.82%
From 52W High-17.38%
1Y MDD-20.05%
Trading
Volume2,054,208 shares
Trading Value$32M